VIT 0.00% 9.6¢ vitura health limited

Vote for Ben Jansen, page-86

  1. 357 Posts.
    lightbulb Created with Sketch. 47
    The present valuation, marked by a P/E ratio of 13, stands significantly below that of all other companies in the same sector, which are universally incurring losses. Moreover, it falls beneath the market average. Vitura is currently being appraised using metrics akin to well-established public companies on the ASX, an unusual scenario for a company experiencing robust growth, with revenues and profits doubling. The perplexing aspect is the continuous decline in its share price. Despite concerted efforts such as investor roadshows, golf days, Bell Potter conferences, and more, it appears that those spearheading these initiatives are failing to generate interest in the company. A pivotal solution might involve bringing fresh perspectives to the board to propel the company out of obscurity and ensure consistent communication with both existing and potential investors. Notably, only about six non-mandated/regulatory notices have been released this year, underscoring the need for a more proactive approach to keeping shareholders informed.

    in my opinion
 
watchlist Created with Sketch. Add VIT (ASX) to my watchlist
(20min delay)
Last
9.6¢
Change
0.000(0.00%)
Mkt cap ! $55.28M
Open High Low Value Volume
9.6¢ 9.8¢ 9.6¢ $24.52K 255.4K

Buyers (Bids)

No. Vol. Price($)
1 5400 9.5¢
 

Sellers (Offers)

Price($) Vol. No.
9.8¢ 74824 4
View Market Depth
Last trade - 15.56pm 20/06/2024 (20 minute delay) ?
VIT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.